Initial experience with the HeartMate percutaneous heart pump in circulatory failure

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10362936" target="_blank" >RIV/00216208:11110/17:10362936 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11120/17:43913423 RIV/00216208:11130/17:10362936 RIV/00023001:_____/17:00076055

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.healun.2017.05.022" target="_blank" >http://dx.doi.org/10.1016/j.healun.2017.05.022</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.healun.2017.05.022" target="_blank" >10.1016/j.healun.2017.05.022</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Initial experience with the HeartMate percutaneous heart pump in circulatory failure

Popis výsledku v původním jazyce

Operative mortality and long-term outcomes of patients undergoing durable ventricular assist device (VAD) implantation are dependent on hemodynamic stability at the time of surgery.1 Survival is worst in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Profile 1 patients.2 Therefore, use of a first-line, short-term mechanical circulatory support in anticipation of durable VAD implantation may be beneficial. In January 2017, the trial enrollment, as well as commercial distribution in Europe, was paused due to mechanical issues leading to pump stoppage. At present, re-engineering efforts are underway to eliminate the failure modes. The purpose of this report is to outline the hemodynamic effects of this novel catheter-based pump technology.

Název v anglickém jazyce

Initial experience with the HeartMate percutaneous heart pump in circulatory failure

Popis výsledku anglicky

Operative mortality and long-term outcomes of patients undergoing durable ventricular assist device (VAD) implantation are dependent on hemodynamic stability at the time of surgery.1 Survival is worst in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Profile 1 patients.2 Therefore, use of a first-line, short-term mechanical circulatory support in anticipation of durable VAD implantation may be beneficial. In January 2017, the trial enrollment, as well as commercial distribution in Europe, was paused due to mechanical issues leading to pump stoppage. At present, re-engineering efforts are underway to eliminate the failure modes. The purpose of this report is to outline the hemodynamic effects of this novel catheter-based pump technology.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

The Journal of Heart and Lung Transplantation

ISSN

1053-2498

e-ISSN

—

Svazek periodika

36

Číslo periodika v rámci svazku

9

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

4

Strana od-do

1016-1019

Kód UT WoS článku

000409395200015

EID výsledku v databázi Scopus

2-s2.0-85020925520